These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24443203)

  • 21. Neoadjuvant chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection. Results of the Quality Assurance in Rectal Cancer Surgery multicenter observational trial.
    Garlipp B; Ptok H; Schmidt U; Meyer F; Gastinger I; Lippert H
    Langenbecks Arch Surg; 2010 Nov; 395(8):1031-8. PubMed ID: 20711786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of laparoscopic anterior resection for rectal adenocarcinoma: retrospective analysis of 157 cases.
    Pugliese R; Di Lernia S; Sansonna F; Scandroglio I; Maggioni D; Ferrari GC; Costanzi A; Magistro C; De Carli S
    Am J Surg; 2008 Feb; 195(2):233-8. PubMed ID: 18083137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial.
    Park JW; Kang SB; Hao J; Lim SB; Choi HS; Kim DW; Chang HJ; Kim DY; Jung KH; Kim TY; Kang GH; Chie EK; Kim SY; Sohn DK; Kim JS; Lee HS; Kim JH; Jeong SY; Oh JH
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):569-577. PubMed ID: 33894918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncological impact of anastomotic leakage after laparoscopic mesorectal excision.
    Hain E; Maggiori L; Manceau G; Mongin C; Prost À la Denise J; Panis Y
    Br J Surg; 2017 Feb; 104(3):288-295. PubMed ID: 27762432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short- and long-term outcome following laparoscopic versus open resection for carcinoma of the rectum in the multimodal setting.
    Kellokumpu IH; Kairaluoma MI; Nuorva KP; Kautiainen HJ; Jantunen IT
    Dis Colon Rectum; 2012 Aug; 55(8):854-63. PubMed ID: 22810470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laparoscopic-assisted versus open total mesorectal excision with anal sphincter preservation for mid and low rectal cancer: a prospective, randomized trial.
    Ng SS; Lee JF; Yiu RY; Li JC; Hon SS; Mak TW; Ngo DK; Leung WW; Leung KL
    Surg Endosc; 2014 Jan; 28(1):297-306. PubMed ID: 24013470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does anastomotic leakage impair functional results and quality of life after laparoscopic sphincter-saving total mesorectal excision for rectal cancer? A case-matched study.
    Mongin C; Maggiori L; Agostini J; Ferron M; Panis Y
    Int J Colorectal Dis; 2014 Apr; 29(4):459-67. PubMed ID: 24477790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robotic versus open total mesorectal excision for rectal cancer: comparative study of short and long-term outcomes.
    Ghezzi TL; Luca F; Valvo M; Corleta OC; Zuccaro M; Cenciarelli S; Biffi R
    Eur J Surg Oncol; 2014 Sep; 40(9):1072-9. PubMed ID: 24646748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic resection of rectal cancer.
    Rosin D; Lebedyev A; Urban D; Aderka D; Zmora O; Khaikin M; Hoffman A; Shabtai M; Ayalon A
    Isr Med Assoc J; 2011 Aug; 13(8):459-62. PubMed ID: 21910368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
    Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
    Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of tumor-specific mesorectal excision for rectal cancer: the impact of laparoscopic resection.
    Mohamed ZK; Law WL
    World J Surg; 2014 Aug; 38(8):2168-74. PubMed ID: 24671302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
    Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
    World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
    Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W;
    JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic total mesorectal excision: a consecutive series of 100 patients.
    Morino M; Parini U; Giraudo G; Salval M; Brachet Contul R; Garrone C
    Ann Surg; 2003 Mar; 237(3):335-42. PubMed ID: 12616116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standardized Laparoscopic Sphincter-preserving Total Mesorectal Excision For Rectal Cancer: Median of 10 Years' Long-term Oncologic Outcome in 217 Unselected Consecutive Patients.
    Bademler S; Koza KB; Ucuncu MZ; Tokmak H; Bakir B; Oral EN; Asoglu O
    Surg Laparosc Endosc Percutan Tech; 2019 Oct; 29(5):354-361. PubMed ID: 31107850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter Analysis of Long-Term Oncologic Impact of Anastomotic Leakage After Laparoscopic Total Mesorectal Excision: The Korean Laparoscopic Colorectal Surgery Study Group.
    Kang J; Choi GS; Oh JH; Kim NK; Park JS; Kim MJ; Lee KY; Baik SH
    Medicine (Baltimore); 2015 Jul; 94(29):e1202. PubMed ID: 26200636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
    Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
    [No Abstract]   [Full Text] [Related]  

  • 39. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
    Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
    Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.
    Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A
    Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.